Efek Minyak Ikan Pada Asma
Abstract
Efek Minyak Ikan pada Asma merupakan referensi yang patut dipertimbangkan untuk menurunkan kasus asma di Indonesia. Buku ini mengulas informasi tentang potensi minyak ikan di Indonesia yang begitu melimpah yang menjadi bahan utama yang patut diperhitungkan dalam pengobatan asma. Selain itu konsep pengobatan asma terkini yang dikaitkan dengan sumber daya alam yang ada di Indonesia termasuk minyak ikan juga dibahas secara rinci dalam buku ini. Kinerja minyak ikan terhadap perbaikan gejala asma, fungsi paru dan pengobatan asma serta perbaikan kualitas hidup juga dikupas dengan detail. Efek secara individual yang disebabkan oleh penggunaan minyak ikan dalam pengobatan asma menjadi salah satu hal yang dipandang perlu oleh penulis untuk dijadikan sebagai bahan pembahasan. Buku yang ditulis oleh 3 orang dosen universitas Surabaya ini juga menambahkan persepsi masyarakat Indonesia dalam penggunaan minyak ikan baik dalam pengobatan asma maupun dalam penggunaan pengobatan yang lainnya.
References
American Academy of Allergy, Asthma & Immunology. 2013, Peak Flow Meter: Tips to
Remember, viewed 1 January 2013
American Lung Association. 2015. Lung Health & Disease: Measuring Your Peak Flow Rate,
viewed 1 December 2015
rate.html?referrer=https://www.google.co.id/>.
Anderson, P.O., Knoben, J.E. and Troutman, W.G. 2002, Handbook of Clinical Drug Data,
10
th
edition, McGraw-Hill Companies, New York. US.
Aprizayanti. Hubungan Konsumsi Omega 3 Terhadap Tumbuh Kembang Anak Usia 2-3
Tahun di Wilayah Kerja Puskesmas Sebarang Padang Kota Padang Tahun
2011.Padang;2011.
Asthma Management Handbook. 2006, National Asthma Council Australia.
Baba, K. and Yamaguchi, E. 2005, Issues Associated with Stepwise Management of Bronchial
Asthma, Allergology International, 54:203-208.
Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik Indonesia.
2008. Riset Kesehatan Dasar (RISKESDAS) 2007.
Baffi CW, Winnica DE, Holguin F. Asthma and obesity: mechanisms and clinical implications.
Asthma Research and Practice. 2015. 1:1.
Basvi, P.T., Dandara, C., Bapiro, T.E., Hasler, A.J. 2007, Role of CYP1A2*1F on CYP1A2
activity in a black African population as determined by caffeine phenotyping. Journal of
Chinese Clinical Medicine, 2(4):211–214.
Baxi SN, Phipatanakul W. The Role of Allergen Exposure and Avoidance in Asthma. Adolesc
Med State Art Rev. 2010 April ; 21(1): 57–ix.
Berger, M.L., Bingefors, K., Hedblom, E.C., Pashos, C.L. and Torrance, G.W. 2003, Health
Care Cost, Quality, and Outcomes: ISPOR Book of Terms, International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) Book of Term, Lawrenceville ,
US.
Belle, D.J dan Singh, H. 2008. Genetic Factors in Drug Metabolism, Am Fam Physician,
77(11):1553-1560.
Bootman, J.L. and Harrison, D.L. 1997, Pharmacoeconomics: Basic Concepts and
Terminology, British and Journal Clinical Pharmacology, 43:343–348.
Bootman, J.L., Townsend, R.J. and McGhan, W.F. 2005, Principles of Pharmacoeconomics,
3rd edition, Harvey Whitney Books Company. US.
Bonds, R. S., & Midoro-Horiuti, T. (2013). Estrogen effects in allergy and asthma. Current
Opinion in Allergy and Clinical Immunology, 13(1), 92–99.
Calder, P.C. 2007. Immunomodulation by omega-3 fatty acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 77, 327–335.
Cazzola, M., Matera, M.G. 2012, Tremor and b2-adrenergic agents: Is it a real clinical problem? Pulmonary Pharmacology & Therapeutics,25:4-10.
Chen E, Miller GE. 2007. Stress and Inflammation in Exacerbations of Asthma. Brain BehavImmun. 21(8):993-999. Chida, M., Yokoi, T., Fukui, T., Kinoshita, M., Yokota, J., Kamataki, T. 1999, Detection of three genetic polymorphisms in the 5′-flanking region and intron I of human CYP1A2 in the Japanese population, Jpn J Cancer Res. 90:899–902.
Cleveland Clinic.2018. Smoking & Asthma. https://my.clevelandclinic.org/health/articles/4584-smoking--asthma Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders Richard N Dalby,1 Joachim Eicher,2 and Bernd Zierenberg. 2011; 4: 145–155.
Diana FM. Omega 3. Jurnal Kesehatan Masyarakat; 2012. Direktorat Bina Farmasi Komunitas dan Klinik. Pharmaceutical Care Untuk Penyakit Asma. Jakarta : Departemen Kesehatan RI; 2007. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Pedoman Pengendalian Penyakit Asma, 2009.
Fal, A.M. and Rosiek-Biegus, M. 2011, Pharmacogenetics of Asthma, in Sanoudou D, Clinical
Applications of Pharmacogenetics, InTech. Kroatia. pp183-200. Fotenko O, Zeki A, Schuster G, Davis C, Allayee H, Stephensen C et al. Asthma patients with specific genotypes identified for fish oil treatment trial. California Agriculture. 2011.
Fukami, T., Nakajima, M., Sakai, H., Katoh, M. and Yokoi, T. 2007, Short Communication: CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline, Drug Metabolism and Disposition, 35(3):335–339.
Gazdik, F., Hrmova, A. and Gazdikova, K. 2001, Pharmacoecomy of Adult Asthmatics, Bratisl Lek Listy, 102(12):575-580.
Ghiculescu, R.A. 2008, Therapeutic drug monitoring: which drugs, why, when and how to do it, Australian Prescriber, 31(2):42–44.
Global Initiative for Asthma (GINA), 2017, Global Strategy for Asthma Management & Prevention (Update). http://www.ginasthma.org/
Hamdy, S. I., Hiratsuka, M., Narahara, K., Endo, N., El-Enany, M., Moursi, N., Ahmed, M. dan Mizugaki, M. 2003, Genotyping of Four Polymorphisms in The CYP1A2 Gene in The Egyptian Population, British Journal of Clinical Parmacology, 55: 321-324.
Hartriani J. 2017. Potensi Besar Laut Indonesia. KATADATA MARKET SENTIMENT
INDEX. https://katadata.co.id/infografik/2017/02/13/potensi-besar-laut-indonesia Impact of Patient Needs on Design and Usage of an Inhalation Device in Respiratory Medicine. Petra Moroni-Zentgraf. Respiratory Drug Delivery Europe 2013 – Moroni-Zentgraf. 2013.
Int J Pharm. 2004 Sep 28;283(1-2):1-9. A review of the development of Respimat Soft Mist Inhaler. Dalby R, Spallek M, Voshaar T.
Issa, A.M. 2003. Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges. Pharmacogenomics, 4(5):1-9. Juniper EF, Wisniewski ME, Cox FM, Emmett AH, Nielsen KE, O’Byrne PM.
Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 2004;23:287-91.
Kelly, H.W. and Sorkness, C. 2011, Asthma, in DiPiro, J., Talbert, R., Yee, G., Matzke, G., Wells, B. and Posey, M., editors, Pharmacotherapy: A Pathophysiologic Approach, 8th edition, McGrawHill, New York. US.
Kementerian Kelautan dan Perikanan (KKP). 2017. Bangun Gizi Masyarakat dengan Gemar Konsumsi Ikan. http://news.kkp.go.id/index.php/bangun-gizi-masyarakat-dengan-gemarkonsumsi-
ikan/Kementerian Kelautan dan Perikanan. 2018. Produktivitas Perikanan Indonesia Pada: Forum Merdeka Barat 9 Kementerian Komunikasi dan Informatika. https://kkp.go.id/wpcontent/ uploads/2018/01/KKP-Dirjen-PDSPKP-FMB-Kominfo-19-Januari-2018.pdf
Keselman A, Heller N. 2015. Estrogen Signaling Modulates Allergic Inflammation and Contributes to Sex Differences in Asthma. Front Immunol. 6:568 Khatri. 2016. Natural Asthma Remedies. WebMD. https://www.webmd.com/asthma/guide/natural-asthma-remedies#2 Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, Jorge F. Maspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D. Hamilton, Brian N. Swanson, Asif Khan, Jingdong Chao, Heribert Staudinger, Gianluca Pirozzi, Christian Antoni, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Neil Stahl, George D. Yancopoulos, Ariel Teper. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe
Asthma. New England Journal of Medicine, 2018; DOI: 10.1056/NEJMoa1804093 KOMINFO JATIM. 2014. Ekspor Ikan Tinggi, Konsumsi Rendah. http://kominfo.jatimprov.go.id/read/laporan-utama/1132
Kurth, J.H. 2000, Pharmacogenomics: Future Promise Of A Tool For Identifying Patients At Risk, Drug Information Journal, 34:223–227.
Lima, J.J., Blake, K.V., Tantisira, K.G. and Weiss, S.T. 2009, Pharmacogenetics of Asthma, Curr Opin Pulm Med, 15(1):57-62.
Lorensia A, Amalia RA. 2015. Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro, Jurnal Ilmiah Manuntung (JIM) Sains Farmasi dan Kesehatan, Akademi Farmasi Samarinda, Mei 2015, Vol. 1, No. 1, p8-18.
Lorensia A, Canggih B, Wijaya RI, 2013a. Analisa Adverse Drug Reactions pada Pasien Asma di Suatu Rumah Sakit, Surabaya. Jurnal Farmasi Indonesia. Vol.6, No. 3, 2013, p.142-150.
Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. 2016. Analisis Kejadian Leukositosis Pasca Terapi Aminofilin Intravena Dibandingkan dengan Salbutamol Nebulasi pada Pasien Eksaserbasi Asma. Indonesia journal of Clinical Pharmacy (IJCP),
Padjajaran university, Vol.5, No. 3, September 2016, p.149-159. Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. 2016b. Comparison of Electrolyte Disturbance of Using Intravenous Aminophylline Versus Nebulization Salbutamol for Exacerbation Asthma in Surabaya, Indonesia. International Journal of Pharmaceutical and Clinical Research 2016; 8(4): 221-228 (ISSN: 0975 1556)
Lorensia A, Ikawati Z, Andayani TM, Maranatha D. 2018. Perbandingan Perbaikan Nilai Peak Ekspiratory Flow Penggunaan Aminofilin dan Salbutamol pada Eksaserbasi Asma. Indonesian Journal of CHEST (Critical and Emergency Medicine). 5(2):34-43.
Lorensia A, Ikawati Z, Andayani TM, Suryadinata RV, Hartoro KAA, Firanita LD. 2018. Efektifitas dan Risiko Toksisitas Aminofilin Intravena Pada Pengobatan Awal Serangan Asma. Indonesia journal of Clinical Pharmacy (IJCP), Padjajaran university. 7(2):78-88.
Lorensia A, Lisiska N, April 2011. “Illness Perceptions Study of Asthma Treatment Compliance in Pharmaceutical Care”. Jurnal ANIMA Indonesian Psychological Journal, UBAYA, Vol. 26, No. 3, 2011, P.184-188.
Lorensia A, Suryadinata RV. 2018. Panduan Lengkap Penggunaan Macam-Macam Alat Inhaler pada Gangguan Pernafasan. CV M-Brothers Indonesia: Surabaya.
Lorensia A, Wahjuningsih E, Sungkono EP. 2015. Hubungan Pengaruh Tingkat Keparahan Asma dengan Kualitas Hidup dalam Memicu Timbulnya Depresi pada Pasien Asma Kronis. Jurnal Ilmiah Sains & Teknologi, Juni 2015. 8(2):21-30.
Lorensia A, Wahjuningsih E, Supriadi, 2012. “Keamanan Penggunaan Aminofilin pada Asma di Rumah Sakit Delta Surya Sidoarjo”. Indonesia journal of Clinical Pharmacy (IJCP), Padjajaran university, Vol.1, No. 4, 2012, p.154-161.
Lorensia A, Wahyudi M, Mayzika NA. 2018. Effectiveness Of Fish Oil Containing Omega-3 In Improving Symptoms And Lung Function In Asthma Outpatient In Surabaya, Indonesia. International Journal Of Pharmaceutical Quality Assurance. 9(3):260-266.
Lorensia A, Wahyudi M, Yudiarso A, Kurnia SED. 2018. EFFECT OF ILLNESS PERCEPTION ON ASMA SYMPTOMS WITH OMEGA-3 FISH OIL IN ASMA OUTPATIENT [Oral Presentation]. The 3rd International Symposium of Public Health.
Organized by Faculty of Public Health, Universitas Airlangga. In Wyndham Hotel, Surabaya. 31 Oktober – 1 November 2018.
Lorensia A, Wijaya RI, Canggih B, 2013b. “Studi Efektifitas Biaya terkait Pemilihan Obat Asma Bronkiale Rawat Inap di Suatu Rumah Sakit Swasta di Surabaya”. Jurnal Ilmiah Sains & Teknologi, Des 2013. 7(1):56-63. (ISSN 0216-1540).
Lorensia A, Wijaya RI. 2016. Hubungan Jumlah Obat yang Digunakan Terhadap Risiko Terjadinya Drug-Related Problems pada Pasien Asma di Suatu Rumah Sakit di Surabaya. Jurnal of Tropical Pharmacy and Chemistry, UNMUL, Vol. 3(3):232-238.
Lorensia A, Yulia R, Wahyuningtyas IS. 2016c. Hubungan Persepsi Penyakit (Illness Perception) dengan Kontrol Gejala Asma pada Pasien Rawat Jalan. Media Pharmaceutica Indonesiana (MPI), UBAYA, Des 2016. Vol. 1(2):92-99.
Lorensia A. 2017. Buku Ajar Farmakoekonomi: Menghadapi Tingginya Lonjakan Biaya Pengobaan yang Mengancam Kestabilan Perekonomian. CV M-Brothers Indonesia: Surabaya.
Lorensia, A., Amalia, R.A., 2015, Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro, Jurnal Ilmiah Manuntung (JIM), 1(1):8-18
Lorensia, A., Amalia, R.A., 2015, Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro, Jurnal Ilmiah Manuntung (JIM), 1(1):8-18.
Makino, S., Adachi, M., Ohta, K., Kihara, N., Nakajima, S., Nishima, S., et al. 2006, A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD, Allergol Int, 55(4):395-402.
Mickleborough TD, Ionescu AA, Rundell KW. Omega-3 Fatty Acids and Airway Hyperresponsiveness in Asthma. J Altern Complement Med. 2004 Dec;10
Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. 2015 Jan;64.
Moamary Mohamed S Al, Al-Kordi Ahmed G, Ghobain Mohammed O Al, et al. Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: a randomized controlled trial. BMC Pulmonary Medicine. 2012; 14. Mohanan S, Tapp H, Mc Williams A, Dulin M. Obesity and asthma: Pathophysiology and implications for diagnosis and management in primary care. Exp Biol Med (Maywood). 2014; 239(11): 1531–1540. Morrow, T.J. 2007, Implications of Pharmacogenomics in the Current and Future Treatment of Asthma, Journal of Managed Care Pharmacy, 13(6):497-505.
Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. (2006). The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest; 129(1):15-26.
Nuttall FQ, Body Mass Index. Obesity, BMI, and Helath: A Critical Review. Nutr Today. 2015. 50(3):117-128. Obase, Y., Shimoda, T., Kawano, T., Saeki, S., Tomari, S.Y. and Mitsuta-Izaki, K., et al. 2003, Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma, Clinical Pharmacology and Therapeutics, 73(5):468-74.
Oemiati, R., 2013. Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK). Media Litbangkes Vol. 23 No. 2, Juni 2013: 82-88 82. Panagan AT, Yohandini H, Gultom JU. Analisi Kualitatif Dan Kuantitatif Asam Lemak Tak Jenuh Omega-3 dari Ikan Patin (Pangasius Pangasius) dengan Metoda Kromatografi Gas. Jurnal Penelitian Sains; 2011.
Piacentini J , Woods DW , Scahill L , et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial . JAMA . 2010 ; 303 : 1929 – 1937.
Pinto LA, Stein RT, Kabesch M. Impact of genetics in childhood asthma. J Pediatr (Rio J). 2008 Aug;84.
Postma DS. 2007. Gender differences in asthma development and progression. Gend Med. 2007;4 Suppl B:S13346.
Queljoe DD, Wahjudi M, Erdiansyah M, Suryadinata RV, Lorensia A. 2014. Studi Pendahuluan Polimorfisme Genetik Gen CYP1A2*1F pada Pasien Asma dan Non-Asma di Indonesia, Indonesia journal of Clinical Pharmacy (IJCP), Padjajaran university, Vol.4, No. 1, Maret 2015, p.8-16.
Rosenkranz RR. Rosenkranz SK. Neessen KJJ. Dietary factors associated with lifetime asthma or hayfever diagnosis in Australian middle-aged and older adults: a cross-sectional study. Nutr J. 2012 Oct 12;11. Santoso A, Iriyanti N, S Tri Rahardjo. Penggunaan Pakan Fungsional Mengandung Omega 3, Probiotik dan Isolat Antihistamin N3 Terhadap Kadar Lemak dan Kolesterol Kuning Ayam Kampung. Jurnal Ilmiah Peternakan;2013.
Schulz, M., Verheyen, F., Muhlig, S., Muller, J.M., Muhlbauer, K. and Knop-Schneickert, E. et al. 2001, Pharmaceutical care services for asthma patients: a controlled intervention study,
The Jornal of Clinical Pharmacology, 41:668-76. Self, T.H., Chrisman, C.R. and Finch, C.K. 2008, Asthma, in Koda-Kimble, M. A., Young, L.Y., Kradjan, W.A., Guglielmo, B.J., Alldredge, B.K. and Corelli, R.L. Applied
Therapeutics – The Clinical Use of Drugs, 9th edition, Lippincort Williams&Wilkins, Philadelphia. US.
Shargel, L., Wu-Pong, S. and Andrew, B.C. 2012, Applied Biopharmaceutics & Pharmacokinetics, 6th edition, McGraw-Hill, New York. US.
Shastry, B.S. 2006, Pharmacogenetics and the concept of individualized medicine, The Pharmacogenomics Journal, 6:16–21.
Shu, Y., Cheng, Z.N., Liu, Z.Q., Wang, L.S., Zhu B. and Huang, S.L., et al. 2001, Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects, Acta pharmacologica Sinica, 22:283-8.
Takata, K., Saruwatari, J., Nakada, N., Nakagawa, M., Fukuda, K. and Tanaka, F., et al. 2006, Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy, European Journal of Clinical Pharmacology, 62(1):23-8.
Tamimi A, Serdarevic D, Hanania NA. 2012. The effects of cigarette smoke on airwayinflammation in asthma and COPD: Therapeutic implications. Respiratory Medicine.106(3):319-328
Tarlo SM, Lemiere C. 2014. Occupational Asthma. N Engl J Med. 370:640-649 Thien FCK, S De Luca, RK Woods, MJ Abramson. Dietary marine fatty acids (fish oil)for asthma in adults and children (Review). Cochrane Database Syst Rev. 2010;2
Tim Publikasi Katadata. 2016. Potensi Bisnis Perikanan di Beranda Indonesia. KATADATA.https://katadata.co.id/infografik/2016/04/12/potensi-bisnis-di-beranda-indonesiaTse, S.M., Tantisira, K. and Weiss, S.T. 2011, The Pharmacogenetics and Pharmacogenomicsof Asthma Therapy, Pharmacogenomics Journal, 11(6):383-392.
Tyagi, N., Gulati, K., Vijayan, V.K. and Ray, A. 2008, A Study to Monitor Adverse DrugReactions in Patients of Chronic Obstructive Pulmonary Disease: Focus on Theophylline,The Indian Journal of Chest Diseases & Allied Sciences, 50:199-202.World Wide Fund, 2015. Kekayaan Laut Mencapai US$ 24 Triliun, Namun Terus Menipis.http://www.wwf.or.id/tentang_wwf/upaya_kami/marine/?uNewsID=38703
Yao, P.L., Tsai, M.F., Lin, Y.C., Wang, C.H., Liao, W.Y. and Chen, J.J.W., et al. 2005, Global expression profiling of theophylline response genes in macrophages: evidence of airwayanti-inflammatory regulation, Respiratory Research, 6:89.
Yasui, K., Agematsu, K., Shinozaki, K., Hokibara, S., Nagumo, H. and Nakazawa, T., et al. 2000, Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism, Journal of Leukocyte Biology, 67(4):529-535.
Yoon, Y., Park, H.D., Park, K.U., Kim, J.Q., Chang, Y.S. and Song, J. 2006, Associationsbetween CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluricacid/theophylline ratios, European Journal of Clinical Pharmacology, 62(8):627-31.
Zaki, S.A. 2011, Adverse drug reaction and causality assessment scales, Lung India,28(2):152–153.
Zhou, H.H., Koshakji, R.P., Silberstein, D.J., Wilkinson, G.R., Wood, A.J.J. 1989, RacialDifferences in Drug Response: Altered Sensitivity to and Clearance of Propranolol in Menof Chinese Descent as Compared with American Whites, New England Journal ofMedicine, 320:565-570.
Zhou, H.H., Sheller, J.R., Wood, M., Wood, A.J. 1990, Caucasians are more sensitive thanChinese to the Cardiovascular and Respiratory effects of Morhipne but Less to TheGastrointestinal Side Effects, Clinical Research, 38:968A.
Remember, viewed 1 January 2013
American Lung Association. 2015. Lung Health & Disease: Measuring Your Peak Flow Rate,
viewed 1 December 2015
rate.html?referrer=https://www.google.co.id/>.
Anderson, P.O., Knoben, J.E. and Troutman, W.G. 2002, Handbook of Clinical Drug Data,
10
th
edition, McGraw-Hill Companies, New York. US.
Aprizayanti. Hubungan Konsumsi Omega 3 Terhadap Tumbuh Kembang Anak Usia 2-3
Tahun di Wilayah Kerja Puskesmas Sebarang Padang Kota Padang Tahun
2011.Padang;2011.
Asthma Management Handbook. 2006, National Asthma Council Australia.
Baba, K. and Yamaguchi, E. 2005, Issues Associated with Stepwise Management of Bronchial
Asthma, Allergology International, 54:203-208.
Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan Republik Indonesia.
2008. Riset Kesehatan Dasar (RISKESDAS) 2007.
Baffi CW, Winnica DE, Holguin F. Asthma and obesity: mechanisms and clinical implications.
Asthma Research and Practice. 2015. 1:1.
Basvi, P.T., Dandara, C., Bapiro, T.E., Hasler, A.J. 2007, Role of CYP1A2*1F on CYP1A2
activity in a black African population as determined by caffeine phenotyping. Journal of
Chinese Clinical Medicine, 2(4):211–214.
Baxi SN, Phipatanakul W. The Role of Allergen Exposure and Avoidance in Asthma. Adolesc
Med State Art Rev. 2010 April ; 21(1): 57–ix.
Berger, M.L., Bingefors, K., Hedblom, E.C., Pashos, C.L. and Torrance, G.W. 2003, Health
Care Cost, Quality, and Outcomes: ISPOR Book of Terms, International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) Book of Term, Lawrenceville ,
US.
Belle, D.J dan Singh, H. 2008. Genetic Factors in Drug Metabolism, Am Fam Physician,
77(11):1553-1560.
Bootman, J.L. and Harrison, D.L. 1997, Pharmacoeconomics: Basic Concepts and
Terminology, British and Journal Clinical Pharmacology, 43:343–348.
Bootman, J.L., Townsend, R.J. and McGhan, W.F. 2005, Principles of Pharmacoeconomics,
3rd edition, Harvey Whitney Books Company. US.
Bonds, R. S., & Midoro-Horiuti, T. (2013). Estrogen effects in allergy and asthma. Current
Opinion in Allergy and Clinical Immunology, 13(1), 92–99.
Calder, P.C. 2007. Immunomodulation by omega-3 fatty acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 77, 327–335.
Cazzola, M., Matera, M.G. 2012, Tremor and b2-adrenergic agents: Is it a real clinical problem? Pulmonary Pharmacology & Therapeutics,25:4-10.
Chen E, Miller GE. 2007. Stress and Inflammation in Exacerbations of Asthma. Brain BehavImmun. 21(8):993-999. Chida, M., Yokoi, T., Fukui, T., Kinoshita, M., Yokota, J., Kamataki, T. 1999, Detection of three genetic polymorphisms in the 5′-flanking region and intron I of human CYP1A2 in the Japanese population, Jpn J Cancer Res. 90:899–902.
Cleveland Clinic.2018. Smoking & Asthma. https://my.clevelandclinic.org/health/articles/4584-smoking--asthma Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders Richard N Dalby,1 Joachim Eicher,2 and Bernd Zierenberg. 2011; 4: 145–155.
Diana FM. Omega 3. Jurnal Kesehatan Masyarakat; 2012. Direktorat Bina Farmasi Komunitas dan Klinik. Pharmaceutical Care Untuk Penyakit Asma. Jakarta : Departemen Kesehatan RI; 2007. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Pedoman Pengendalian Penyakit Asma, 2009.
Fal, A.M. and Rosiek-Biegus, M. 2011, Pharmacogenetics of Asthma, in Sanoudou D, Clinical
Applications of Pharmacogenetics, InTech. Kroatia. pp183-200. Fotenko O, Zeki A, Schuster G, Davis C, Allayee H, Stephensen C et al. Asthma patients with specific genotypes identified for fish oil treatment trial. California Agriculture. 2011.
Fukami, T., Nakajima, M., Sakai, H., Katoh, M. and Yokoi, T. 2007, Short Communication: CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline, Drug Metabolism and Disposition, 35(3):335–339.
Gazdik, F., Hrmova, A. and Gazdikova, K. 2001, Pharmacoecomy of Adult Asthmatics, Bratisl Lek Listy, 102(12):575-580.
Ghiculescu, R.A. 2008, Therapeutic drug monitoring: which drugs, why, when and how to do it, Australian Prescriber, 31(2):42–44.
Global Initiative for Asthma (GINA), 2017, Global Strategy for Asthma Management & Prevention (Update). http://www.ginasthma.org/
Hamdy, S. I., Hiratsuka, M., Narahara, K., Endo, N., El-Enany, M., Moursi, N., Ahmed, M. dan Mizugaki, M. 2003, Genotyping of Four Polymorphisms in The CYP1A2 Gene in The Egyptian Population, British Journal of Clinical Parmacology, 55: 321-324.
Hartriani J. 2017. Potensi Besar Laut Indonesia. KATADATA MARKET SENTIMENT
INDEX. https://katadata.co.id/infografik/2017/02/13/potensi-besar-laut-indonesia Impact of Patient Needs on Design and Usage of an Inhalation Device in Respiratory Medicine. Petra Moroni-Zentgraf. Respiratory Drug Delivery Europe 2013 – Moroni-Zentgraf. 2013.
Int J Pharm. 2004 Sep 28;283(1-2):1-9. A review of the development of Respimat Soft Mist Inhaler. Dalby R, Spallek M, Voshaar T.
Issa, A.M. 2003. Pharmacogenomic profiling in postmarketing surveillance: prospects and challenges. Pharmacogenomics, 4(5):1-9. Juniper EF, Wisniewski ME, Cox FM, Emmett AH, Nielsen KE, O’Byrne PM.
Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 2004;23:287-91.
Kelly, H.W. and Sorkness, C. 2011, Asthma, in DiPiro, J., Talbert, R., Yee, G., Matzke, G., Wells, B. and Posey, M., editors, Pharmacotherapy: A Pathophysiologic Approach, 8th edition, McGrawHill, New York. US.
Kementerian Kelautan dan Perikanan (KKP). 2017. Bangun Gizi Masyarakat dengan Gemar Konsumsi Ikan. http://news.kkp.go.id/index.php/bangun-gizi-masyarakat-dengan-gemarkonsumsi-
ikan/Kementerian Kelautan dan Perikanan. 2018. Produktivitas Perikanan Indonesia Pada: Forum Merdeka Barat 9 Kementerian Komunikasi dan Informatika. https://kkp.go.id/wpcontent/ uploads/2018/01/KKP-Dirjen-PDSPKP-FMB-Kominfo-19-Januari-2018.pdf
Keselman A, Heller N. 2015. Estrogen Signaling Modulates Allergic Inflammation and Contributes to Sex Differences in Asthma. Front Immunol. 6:568 Khatri. 2016. Natural Asthma Remedies. WebMD. https://www.webmd.com/asthma/guide/natural-asthma-remedies#2 Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, Jorge F. Maspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D. Hamilton, Brian N. Swanson, Asif Khan, Jingdong Chao, Heribert Staudinger, Gianluca Pirozzi, Christian Antoni, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Neil Stahl, George D. Yancopoulos, Ariel Teper. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe
Asthma. New England Journal of Medicine, 2018; DOI: 10.1056/NEJMoa1804093 KOMINFO JATIM. 2014. Ekspor Ikan Tinggi, Konsumsi Rendah. http://kominfo.jatimprov.go.id/read/laporan-utama/1132
Kurth, J.H. 2000, Pharmacogenomics: Future Promise Of A Tool For Identifying Patients At Risk, Drug Information Journal, 34:223–227.
Lima, J.J., Blake, K.V., Tantisira, K.G. and Weiss, S.T. 2009, Pharmacogenetics of Asthma, Curr Opin Pulm Med, 15(1):57-62.
Lorensia A, Amalia RA. 2015. Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro, Jurnal Ilmiah Manuntung (JIM) Sains Farmasi dan Kesehatan, Akademi Farmasi Samarinda, Mei 2015, Vol. 1, No. 1, p8-18.
Lorensia A, Canggih B, Wijaya RI, 2013a. Analisa Adverse Drug Reactions pada Pasien Asma di Suatu Rumah Sakit, Surabaya. Jurnal Farmasi Indonesia. Vol.6, No. 3, 2013, p.142-150.
Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. 2016. Analisis Kejadian Leukositosis Pasca Terapi Aminofilin Intravena Dibandingkan dengan Salbutamol Nebulasi pada Pasien Eksaserbasi Asma. Indonesia journal of Clinical Pharmacy (IJCP),
Padjajaran university, Vol.5, No. 3, September 2016, p.149-159. Lorensia A, Ikawati Z, Andayani TM, Maranatha D, Wahjudi M. 2016b. Comparison of Electrolyte Disturbance of Using Intravenous Aminophylline Versus Nebulization Salbutamol for Exacerbation Asthma in Surabaya, Indonesia. International Journal of Pharmaceutical and Clinical Research 2016; 8(4): 221-228 (ISSN: 0975 1556)
Lorensia A, Ikawati Z, Andayani TM, Maranatha D. 2018. Perbandingan Perbaikan Nilai Peak Ekspiratory Flow Penggunaan Aminofilin dan Salbutamol pada Eksaserbasi Asma. Indonesian Journal of CHEST (Critical and Emergency Medicine). 5(2):34-43.
Lorensia A, Ikawati Z, Andayani TM, Suryadinata RV, Hartoro KAA, Firanita LD. 2018. Efektifitas dan Risiko Toksisitas Aminofilin Intravena Pada Pengobatan Awal Serangan Asma. Indonesia journal of Clinical Pharmacy (IJCP), Padjajaran university. 7(2):78-88.
Lorensia A, Lisiska N, April 2011. “Illness Perceptions Study of Asthma Treatment Compliance in Pharmaceutical Care”. Jurnal ANIMA Indonesian Psychological Journal, UBAYA, Vol. 26, No. 3, 2011, P.184-188.
Lorensia A, Suryadinata RV. 2018. Panduan Lengkap Penggunaan Macam-Macam Alat Inhaler pada Gangguan Pernafasan. CV M-Brothers Indonesia: Surabaya.
Lorensia A, Wahjuningsih E, Sungkono EP. 2015. Hubungan Pengaruh Tingkat Keparahan Asma dengan Kualitas Hidup dalam Memicu Timbulnya Depresi pada Pasien Asma Kronis. Jurnal Ilmiah Sains & Teknologi, Juni 2015. 8(2):21-30.
Lorensia A, Wahjuningsih E, Supriadi, 2012. “Keamanan Penggunaan Aminofilin pada Asma di Rumah Sakit Delta Surya Sidoarjo”. Indonesia journal of Clinical Pharmacy (IJCP), Padjajaran university, Vol.1, No. 4, 2012, p.154-161.
Lorensia A, Wahyudi M, Mayzika NA. 2018. Effectiveness Of Fish Oil Containing Omega-3 In Improving Symptoms And Lung Function In Asthma Outpatient In Surabaya, Indonesia. International Journal Of Pharmaceutical Quality Assurance. 9(3):260-266.
Lorensia A, Wahyudi M, Yudiarso A, Kurnia SED. 2018. EFFECT OF ILLNESS PERCEPTION ON ASMA SYMPTOMS WITH OMEGA-3 FISH OIL IN ASMA OUTPATIENT [Oral Presentation]. The 3rd International Symposium of Public Health.
Organized by Faculty of Public Health, Universitas Airlangga. In Wyndham Hotel, Surabaya. 31 Oktober – 1 November 2018.
Lorensia A, Wijaya RI, Canggih B, 2013b. “Studi Efektifitas Biaya terkait Pemilihan Obat Asma Bronkiale Rawat Inap di Suatu Rumah Sakit Swasta di Surabaya”. Jurnal Ilmiah Sains & Teknologi, Des 2013. 7(1):56-63. (ISSN 0216-1540).
Lorensia A, Wijaya RI. 2016. Hubungan Jumlah Obat yang Digunakan Terhadap Risiko Terjadinya Drug-Related Problems pada Pasien Asma di Suatu Rumah Sakit di Surabaya. Jurnal of Tropical Pharmacy and Chemistry, UNMUL, Vol. 3(3):232-238.
Lorensia A, Yulia R, Wahyuningtyas IS. 2016c. Hubungan Persepsi Penyakit (Illness Perception) dengan Kontrol Gejala Asma pada Pasien Rawat Jalan. Media Pharmaceutica Indonesiana (MPI), UBAYA, Des 2016. Vol. 1(2):92-99.
Lorensia A. 2017. Buku Ajar Farmakoekonomi: Menghadapi Tingginya Lonjakan Biaya Pengobaan yang Mengancam Kestabilan Perekonomian. CV M-Brothers Indonesia: Surabaya.
Lorensia, A., Amalia, R.A., 2015, Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro, Jurnal Ilmiah Manuntung (JIM), 1(1):8-18
Lorensia, A., Amalia, R.A., 2015, Studi Farmakovigilans Pengobatan Asma pada Pasien Rawat Inap di suatu Rumah Sakit di Bojonegoro, Jurnal Ilmiah Manuntung (JIM), 1(1):8-18.
Makino, S., Adachi, M., Ohta, K., Kihara, N., Nakajima, S., Nishima, S., et al. 2006, A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD, Allergol Int, 55(4):395-402.
Mickleborough TD, Ionescu AA, Rundell KW. Omega-3 Fatty Acids and Airway Hyperresponsiveness in Asthma. J Altern Complement Med. 2004 Dec;10
Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. 2015 Jan;64.
Moamary Mohamed S Al, Al-Kordi Ahmed G, Ghobain Mohammed O Al, et al. Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: a randomized controlled trial. BMC Pulmonary Medicine. 2012; 14. Mohanan S, Tapp H, Mc Williams A, Dulin M. Obesity and asthma: Pathophysiology and implications for diagnosis and management in primary care. Exp Biol Med (Maywood). 2014; 239(11): 1531–1540. Morrow, T.J. 2007, Implications of Pharmacogenomics in the Current and Future Treatment of Asthma, Journal of Managed Care Pharmacy, 13(6):497-505.
Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. (2006). The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest; 129(1):15-26.
Nuttall FQ, Body Mass Index. Obesity, BMI, and Helath: A Critical Review. Nutr Today. 2015. 50(3):117-128. Obase, Y., Shimoda, T., Kawano, T., Saeki, S., Tomari, S.Y. and Mitsuta-Izaki, K., et al. 2003, Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma, Clinical Pharmacology and Therapeutics, 73(5):468-74.
Oemiati, R., 2013. Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK). Media Litbangkes Vol. 23 No. 2, Juni 2013: 82-88 82. Panagan AT, Yohandini H, Gultom JU. Analisi Kualitatif Dan Kuantitatif Asam Lemak Tak Jenuh Omega-3 dari Ikan Patin (Pangasius Pangasius) dengan Metoda Kromatografi Gas. Jurnal Penelitian Sains; 2011.
Piacentini J , Woods DW , Scahill L , et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial . JAMA . 2010 ; 303 : 1929 – 1937.
Pinto LA, Stein RT, Kabesch M. Impact of genetics in childhood asthma. J Pediatr (Rio J). 2008 Aug;84.
Postma DS. 2007. Gender differences in asthma development and progression. Gend Med. 2007;4 Suppl B:S13346.
Queljoe DD, Wahjudi M, Erdiansyah M, Suryadinata RV, Lorensia A. 2014. Studi Pendahuluan Polimorfisme Genetik Gen CYP1A2*1F pada Pasien Asma dan Non-Asma di Indonesia, Indonesia journal of Clinical Pharmacy (IJCP), Padjajaran university, Vol.4, No. 1, Maret 2015, p.8-16.
Rosenkranz RR. Rosenkranz SK. Neessen KJJ. Dietary factors associated with lifetime asthma or hayfever diagnosis in Australian middle-aged and older adults: a cross-sectional study. Nutr J. 2012 Oct 12;11. Santoso A, Iriyanti N, S Tri Rahardjo. Penggunaan Pakan Fungsional Mengandung Omega 3, Probiotik dan Isolat Antihistamin N3 Terhadap Kadar Lemak dan Kolesterol Kuning Ayam Kampung. Jurnal Ilmiah Peternakan;2013.
Schulz, M., Verheyen, F., Muhlig, S., Muller, J.M., Muhlbauer, K. and Knop-Schneickert, E. et al. 2001, Pharmaceutical care services for asthma patients: a controlled intervention study,
The Jornal of Clinical Pharmacology, 41:668-76. Self, T.H., Chrisman, C.R. and Finch, C.K. 2008, Asthma, in Koda-Kimble, M. A., Young, L.Y., Kradjan, W.A., Guglielmo, B.J., Alldredge, B.K. and Corelli, R.L. Applied
Therapeutics – The Clinical Use of Drugs, 9th edition, Lippincort Williams&Wilkins, Philadelphia. US.
Shargel, L., Wu-Pong, S. and Andrew, B.C. 2012, Applied Biopharmaceutics & Pharmacokinetics, 6th edition, McGraw-Hill, New York. US.
Shastry, B.S. 2006, Pharmacogenetics and the concept of individualized medicine, The Pharmacogenomics Journal, 6:16–21.
Shu, Y., Cheng, Z.N., Liu, Z.Q., Wang, L.S., Zhu B. and Huang, S.L., et al. 2001, Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects, Acta pharmacologica Sinica, 22:283-8.
Takata, K., Saruwatari, J., Nakada, N., Nakagawa, M., Fukuda, K. and Tanaka, F., et al. 2006, Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy, European Journal of Clinical Pharmacology, 62(1):23-8.
Tamimi A, Serdarevic D, Hanania NA. 2012. The effects of cigarette smoke on airwayinflammation in asthma and COPD: Therapeutic implications. Respiratory Medicine.106(3):319-328
Tarlo SM, Lemiere C. 2014. Occupational Asthma. N Engl J Med. 370:640-649 Thien FCK, S De Luca, RK Woods, MJ Abramson. Dietary marine fatty acids (fish oil)for asthma in adults and children (Review). Cochrane Database Syst Rev. 2010;2
Tim Publikasi Katadata. 2016. Potensi Bisnis Perikanan di Beranda Indonesia. KATADATA.https://katadata.co.id/infografik/2016/04/12/potensi-bisnis-di-beranda-indonesiaTse, S.M., Tantisira, K. and Weiss, S.T. 2011, The Pharmacogenetics and Pharmacogenomicsof Asthma Therapy, Pharmacogenomics Journal, 11(6):383-392.
Tyagi, N., Gulati, K., Vijayan, V.K. and Ray, A. 2008, A Study to Monitor Adverse DrugReactions in Patients of Chronic Obstructive Pulmonary Disease: Focus on Theophylline,The Indian Journal of Chest Diseases & Allied Sciences, 50:199-202.World Wide Fund, 2015. Kekayaan Laut Mencapai US$ 24 Triliun, Namun Terus Menipis.http://www.wwf.or.id/tentang_wwf/upaya_kami/marine/?uNewsID=38703
Yao, P.L., Tsai, M.F., Lin, Y.C., Wang, C.H., Liao, W.Y. and Chen, J.J.W., et al. 2005, Global expression profiling of theophylline response genes in macrophages: evidence of airwayanti-inflammatory regulation, Respiratory Research, 6:89.
Yasui, K., Agematsu, K., Shinozaki, K., Hokibara, S., Nagumo, H. and Nakazawa, T., et al. 2000, Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism, Journal of Leukocyte Biology, 67(4):529-535.
Yoon, Y., Park, H.D., Park, K.U., Kim, J.Q., Chang, Y.S. and Song, J. 2006, Associationsbetween CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluricacid/theophylline ratios, European Journal of Clinical Pharmacology, 62(8):627-31.
Zaki, S.A. 2011, Adverse drug reaction and causality assessment scales, Lung India,28(2):152–153.
Zhou, H.H., Koshakji, R.P., Silberstein, D.J., Wilkinson, G.R., Wood, A.J.J. 1989, RacialDifferences in Drug Response: Altered Sensitivity to and Clearance of Propranolol in Menof Chinese Descent as Compared with American Whites, New England Journal ofMedicine, 320:565-570.
Zhou, H.H., Sheller, J.R., Wood, M., Wood, A.J. 1990, Caucasians are more sensitive thanChinese to the Cardiovascular and Respiratory effects of Morhipne but Less to TheGastrointestinal Side Effects, Clinical Research, 38:968A.
